KILITCHPharmaceuticals
Kilitch Drugs India Ltd — Balance Sheet
₹124.45
-9.06%
Kilitch Drugs India Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 1.61 Cr | 1.61 Cr | 1.56 Cr | 1.56 Cr | — |
| Share Issued | 1.61 Cr | 1.61 Cr | 1.56 Cr | 1.56 Cr | — |
| Net Debt | 39.62 Cr | 12.74 Cr | 2.40 Cr | 10.42 Cr | — |
| Total Debt | 49.42 Cr | 31.65 Cr | 22.19 Cr | 20.43 Cr | — |
| Tangible Book Value | 183.44 Cr | 156.47 Cr | 131.11 Cr | 117.79 Cr | — |
| Invested Capital | 251.75 Cr | 207.94 Cr | 173.79 Cr | 159.52 Cr | — |
| Working Capital | 89.61 Cr | 81.78 Cr | 57.53 Cr | 44.83 Cr | — |
| Net Tangible Assets | 183.44 Cr | 156.47 Cr | 131.11 Cr | 117.79 Cr | — |
| Common Stock Equity | 202.33 Cr | 176.29 Cr | 151.60 Cr | 139.09 Cr | — |
| Total Capitalization | 230.10 Cr | 176.29 Cr | 151.60 Cr | 139.09 Cr | — |
| Total Equity Gross Minority Interest | 200.46 Cr | 175.67 Cr | 150.58 Cr | 140.29 Cr | — |
| Minority Interest | -1.87 Cr | -0.62 Cr | -1.02 Cr | 1.21 Cr | — |
| Stockholders Equity | 202.33 Cr | 176.29 Cr | 151.60 Cr | 139.09 Cr | — |
| Other Equity Interest | 186.25 Cr | 0.35 Cr | 5.35 Cr | 2.85 Cr | — |
| Capital Stock | 16.08 Cr | 16.08 Cr | 15.58 Cr | 15.58 Cr | — |
| Common Stock | 16.08 Cr | 16.08 Cr | 15.58 Cr | 15.58 Cr | — |
| Total Liabilities Net Minority Interest | 112.33 Cr | 64.39 Cr | 68.94 Cr | 69.55 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 28.02 Cr | 0.17 Cr | 0.07 Cr | 0.28 Cr | — |
| Long Term Debt And Capital Lease Obligation | 27.77 Cr | — | — | — | — |
| Long Term Debt | 27.77 Cr | — | — | — | — |
| Long Term Provisions | 0.25 Cr | 0.17 Cr | 0.07 Cr | 0.28 Cr | — |
| Current Liabilities | 84.31 Cr | 64.22 Cr | 68.87 Cr | 69.28 Cr | — |
| Other Current Liabilities | 0.26 Cr | 0.21 Cr | 0.08 Cr | 0.10 Cr | — |
| Current Debt And Capital Lease Obligation | 21.65 Cr | 31.65 Cr | 22.19 Cr | 20.43 Cr | — |
| Current Debt | 21.65 Cr | 31.65 Cr | 22.19 Cr | 20.43 Cr | — |
| Current Provisions | 1.48 Cr | 1.39 Cr | 1.52 Cr | 37000.00 | — |
| Payables | 60.84 Cr | 25.87 Cr | 41.04 Cr | 43.35 Cr | — |
| Total Tax Payable | 6.69 Cr | 5.31 Cr | 4.04 Cr | 4.40 Cr | — |
| Accounts Payable | 54.16 Cr | 25.59 Cr | 40.87 Cr | 42.87 Cr | — |
| Total Assets | 312.78 Cr | 240.06 Cr | 219.52 Cr | 209.85 Cr | — |
| Total Non Current Assets | 138.87 Cr | 94.07 Cr | 93.12 Cr | 95.74 Cr | — |
| Non Current Deferred Taxes Assets | 2.88 Cr | 2.56 Cr | 1.98 Cr | 1.51 Cr | — |
| Investmentin Financial Assets | 22.86 Cr | 1.62 Cr | 1.40 Cr | 3.62 Cr | — |
| Available For Sale Securities | 22.86 Cr | 1.62 Cr | 1.40 Cr | 3.62 Cr | — |
| Goodwill And Other Intangible Assets | 18.89 Cr | 19.82 Cr | 20.48 Cr | 21.30 Cr | — |
| Other Intangible Assets | 18.89 Cr | 0.44 Cr | 0.26 Cr | 0.23 Cr | — |
| Net PPE | 92.82 Cr | 48.12 Cr | 47.36 Cr | 46.40 Cr | — |
| Gross PPE | 92.82 Cr | 75.52 Cr | 72.35 Cr | 68.70 Cr | — |
| Construction In Progress | 47.29 Cr | 5.96 Cr | 3.62 Cr | 3.16 Cr | — |
| Other Properties | 45.52 Cr | 3.70 Cr | 3.53 Cr | 3.41 Cr | — |
| Current Assets | 173.92 Cr | 145.99 Cr | 126.40 Cr | 114.10 Cr | — |
| Other Current Assets | 14.47 Cr | 1000.00 | 10.87 Cr | -1000.00 | — |
| Inventory | 15.31 Cr | 5.58 Cr | 2.41 Cr | 5.29 Cr | — |
| Accounts Receivable | 84.74 Cr | 63.22 Cr | 54.29 Cr | 41.41 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 59.40 Cr | 69.02 Cr | 59.12 Cr | 57.24 Cr | — |
| Other Short Term Investments | 49.60 Cr | 50.11 Cr | 39.33 Cr | 47.23 Cr | — |
| Cash And Cash Equivalents | 9.80 Cr | 18.91 Cr | 19.79 Cr | 10.01 Cr | — |
| Retained Earnings | — | 84.23 Cr | 69.63 Cr | 59.18 Cr | 51.82 Cr |
| Additional Paid In Capital | — | 46.68 Cr | 38.33 Cr | 38.33 Cr | 38.33 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 0.17 Cr | 0.07 Cr | 0.28 Cr | 0.38 Cr |
| Current Deferred Taxes Liabilities | — | 5.31 Cr | 4.04 Cr | 4.40 Cr | 2.62 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 1.39 Cr | 1.52 Cr | 1.01 Cr | 0.83 Cr |
| Other Payable | — | 0.25 Cr | 0.13 Cr | 0.44 Cr | 0.12 Cr |
| Dividends Payable | — | 0.04 Cr | 0.04 Cr | 0.04 Cr | 0.04 Cr |
| Other Non Current Assets | — | -2000.00 | 2000.00 | -0.02 Cr | -20000.00 |
| Non Current Prepaid Assets | — | 0.72 Cr | 0.62 Cr | 0.46 Cr | 0.44 Cr |
| Long Term Equity Investment | — | 21.22 Cr | 21.27 Cr | 22.46 Cr | 22.46 Cr |
| Investments In Other Ventures Under Equity Method | — | 21.22 Cr | 21.27 Cr | 22.46 Cr | 22.46 Cr |
| Goodwill | — | 19.38 Cr | 20.22 Cr | 21.06 Cr | 21.91 Cr |
| Accumulated Depreciation | — | -27.39 Cr | -25.00 Cr | -22.30 Cr | -20.69 Cr |
| Machinery Furniture Equipment | — | 53.17 Cr | 52.59 Cr | 49.58 Cr | 20.00 Cr |
| Buildings And Improvements | — | 4.00 Cr | 4.00 Cr | 3.94 Cr | 3.94 Cr |
| Land And Improvements | — | 8.68 Cr | 8.61 Cr | 8.61 Cr | 1.27 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.05 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr |
| Prepaid Assets | — | 8.08 Cr | 10.51 Cr | 10.09 Cr | 4.94 Cr |
| Finished Goods | — | 2.14 Cr | 0.81 Cr | 0.73 Cr | 0.45 Cr |
| Work In Process | — | 0.19 Cr | 0.17 Cr | 0.40 Cr | 0.35 Cr |
| Raw Materials | — | 3.25 Cr | 1.43 Cr | 4.16 Cr | 2.79 Cr |
| Other Receivables | — | 0.03 Cr | 0.02 Cr | 0.02 Cr | 0.02 Cr |
| Allowance For Doubtful Accounts Receivable | — | -9.13 Cr | -6.77 Cr | -4.24 Cr | -3.32 Cr |
| Gross Accounts Receivable | — | 72.35 Cr | 61.05 Cr | 45.65 Cr | 26.24 Cr |
| Cash Equivalents | — | 10.58 Cr | 0.55 Cr | 0.00 | — |
| Cash Financial | — | 8.33 Cr | 19.24 Cr | 10.01 Cr | 12.45 Cr |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | — | — | — | 0.48 Cr | 0.43 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Kilitch Drugs India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.